These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15735794)

  • 1. The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.
    Scanavini D; Legnani C; Lunghi B; Mingozzi F; Palareti G; Bernardi F
    Thromb Haemost; 2005 Mar; 93(3):453-6. PubMed ID: 15735794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.
    Nossent AY; Eikenboom JC; Vos HL; Bakker E; Tanis BC; Doggen CJ; Bertina RM; Rosendaal FR
    Thromb Haemost; 2006 Jun; 95(6):942-8. PubMed ID: 16732372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C in women using oral contraceptives.
    Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W
    Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
    Kovac M; Kovac Z; Tomasevic Z; Vucicevic S; Djordjevic V; Pruner I; Radojkovic D
    Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
    Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T
    Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method-dependent influence of certain polymorphisms in the factor V B-domain on the response to activated protein C.
    Siegert G; Kostka H; Gehrisch S; Schwarz T; Schellong S; Jaross W
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):519-27. PubMed ID: 10997791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL; Welsh CH; Qamar Z; Marlar RA
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
    Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
    Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.
    Vormittag R; Bencur P; Ay C; Tengler T; Vukovich T; Quehenberger P; Mannhalter C; Pabinger I
    J Thromb Haemost; 2007 Mar; 5(3):497-502. PubMed ID: 17155964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
    Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
    Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.